Home
Ottar Kjell Nygård's picture

Ottar Kjell Nygård

Professor
  • E-mailOttar.Nygard@uib.no
  • Phone+47 55 97 30 64
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) 2019. The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study. Brain, behavior, and immunity. 155-162.
  • Show author(s) 2019. The associations between cognitive prognosis and kynurenines are modified by the apolipoprotein ε4 allele variant in patients with dementia. International Journal of Tryptophan Research (IJTR). 1-8.
  • Show author(s) 2019. Short-term treatment with a peroxisome proliferator-activated receptor α agonist influences plasma one-carbon metabolites and B-vitamin status in rats. PLOS ONE. 1-13.
  • Show author(s) 2019. Hypertensive pregnancy disorders increase the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors. International Journal of Cardiology. 81-87.
  • Show author(s) 2019. Dietary choline is related to increased risk of acute myocardial infarction in patients with stable angina pectoris. Biochimie.
  • Show author(s) 2019. A mitochondria-targeted fatty acid analogue influences hepatic glucose metabolism and reduces the plasma insulin/glucose ratio in male Wistar rats. PLOS ONE. 1-17.
  • Show author(s) 2018. Usefulness of higher levels of cardiac troponin T in patients with stable angina pectoris to predict risk of acute myocardial infarction. American Journal of Cardiology. 1142-1147.
  • Show author(s) 2018. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial. Journal of Internal Medicine. 232-244.
  • Show author(s) 2018. Total and lean fish intake is positively associated with bone mineral density in older women in the community-based Hordaland Health Study. European Journal of Nutrition. 1-11.
  • Show author(s) 2018. The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A. European Journal of Preventive Cardiology (EJPC). 1612-1620.
  • Show author(s) 2018. Serum carnitine metabolites and incident type 2 diabetes mellitus in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism. 1033-1041.
  • Show author(s) 2018. Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors. Atherosclerosis. 175-181.
  • Show author(s) 2018. Plasma cystathionine and risk of incident stroke in patients with suspected stable angina pectoris. Journal of the American Heart Association (JAHA). 12 pages.
  • Show author(s) 2018. Plasma cystathionine and risk of acute myocardial infarction among patients with coronary heart disease: Results from two independent cohorts. International Journal of Cardiology. 24-30.
  • Show author(s) 2018. Plasma choline, homocysteine and vitamin status in healthy adults supplemented with krill oil: a pilot study. Scandinavian Journal of Clinical and Laboratory Investigation. 1-7.
  • Show author(s) 2018. Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism. 1161-1170.
  • Show author(s) 2018. Performance of plasma trigonelline as a marker of coffee consumption in an epidemiologic setting. American Journal of Clinical Nutrition. 941-947.
  • Show author(s) 2018. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans. The FASEB Journal. 6019-6024.
  • Show author(s) 2018. Inflammatory markers, the tryptophan-kynurenine pathway, and Vitamin B status after bariatric surgery. PLOS ONE. 1-14.
  • Show author(s) 2018. Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. International Journal of Cardiology. 7 pages.
  • Show author(s) 2018. Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease. Thrombosis and Haemostasis. 778-790.
  • Show author(s) 2018. Ceramide stearic to palmitic acid ratio predicts incident diabetes. Diabetologia. 1424-1434.
  • Show author(s) 2018. Association between gestational hypertension and risk of cardiovascular disease among 617 589 Norwegian women. Journal of the American Heart Association (JAHA). 14 pages.
  • Show author(s) 2018. Adherence to the Healthy Nordic Food Index and the incidence of acute myocardial infarction and mortality among patients with stable angina pectoris. Journal of human nutrition and dietetics. 86-97.
  • Show author(s) 2017. Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: A randomized controlled trial. American Journal of Clinical Nutrition. 85-99.
  • Show author(s) 2017. Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: A Cardiovascular Disease in Norway project. European Journal of Preventive Cardiology (EJPC). 971-980.
  • Show author(s) 2017. Time trends and educational inequalities in out-of-hospital coronary deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) project. Journal of the American Heart Association (JAHA). 8 pages.
  • Show author(s) 2017. The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease. Diabetologia. 1712-1721.
  • Show author(s) 2017. Smoking, plasma cotinine and risk of atrial fibrillation: the Hordaland Health Study. Journal of Internal Medicine. 73-82.
  • Show author(s) 2017. Serum acylcarnitines and risk of cardiovascular death and acute myocardial infarction in patients with stable angina pectoris. Journal of the American Heart Association (JAHA). 1-28.
  • Show author(s) 2017. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. The Lancet Diabetes and Endocrinology. 534-543.
  • Show author(s) 2017. Ratios of one-carbon metabolites are functional markers of B-vitamin status in a Norwegian coronary angiography screening cohort. Journal of Nutrition. 1167-1173.
  • Show author(s) 2017. Prognostic impact of in-hospital and postdischarge heart failure in patients with acute myocardial infarction: a nationwide analysis using data from the Cardiovascular Disease in Norway (CVDNOR) Project. Journal of the American Heart Association (JAHA). 17 pages.
  • Show author(s) 2017. Neopterin as an effect modifier of the cardiovascular risk predicted by total homocysteine: A prospective 2-cohort study. Journal of the American Heart Association (JAHA). 1-17.
  • Show author(s) 2017. Metabolomic evaluation of the consequences of plasma cystathionine elevation in adults with stable angina pectoris. Journal of Nutrition. 1658-1668.
  • Show author(s) 2017. Incident coronary heart disease after Preeclampsia: Role of reduced fetal growth, preterm delivery, and parity. Journal of the American Heart Association (JAHA). 13 pages.
  • Show author(s) 2017. Dietary choline intake is directly associated with bone mineral density in the Hordaland Health Study. Journal of Nutrition. 572-578.
  • Show author(s) 2017. Cardiovascular disease risk associated with serum apolipoprotein B is modified by serum vitamin A. Atherosclerosis. 325-330.
  • Show author(s) 2017. B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials. Journal of Bone and Mineral Research. 1981-1989.
  • Show author(s) 2017. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease. European Journal of Nutrition. 261-272.
  • Show author(s) 2017. Associations between fish intake and the metabolic syndrome and its components among middle-aged men and women: the Hordaland Health Study. Food & Nutrition Research. 11 pages.
  • Show author(s) 2016. Vitamin B-6 catabolism and long-term mortality risk in patients with coronary artery disease. American Journal of Clinical Nutrition. 1417-1425.
  • Show author(s) 2016. The universal 2012 definition of myocardial infarction compared to the 2007 definition. Scandinavian Cardiovascular Journal. 201-205.
  • Show author(s) 2016. The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. Journal of Hypertension. 132-139.
  • Show author(s) 2016. Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice. Lipids in Health and Disease. 16 pages.
  • Show author(s) 2016. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Lipids in Health and Disease.
  • Show author(s) 2016. Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clinical Chemistry. 755-765.
  • Show author(s) 2016. Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris. Journal of the American Heart Association (JAHA). 9 pages.
  • Show author(s) 2016. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. European Heart Journal. 1967-1976.
  • Show author(s) 2016. Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study. American Journal of Epidemiology. 249-258.
  • Show author(s) 2016. Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats. Nutrients.
  • Show author(s) 2016. Methylenetetrahydrofolate dehydrogenase 1 polymorphisms modify the associations of plasma glycine and serine with risk of acute myocardial infarction in patients with stable angina pectoris in WENBIT (Western Norway B Vitamin Intervention Trial). Circulation: Cardiovascular Genetics. 541-547.
  • Show author(s) 2016. Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1743-1750.
  • Show author(s) 2016. Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project. Journal of the American Heart Association (JAHA). 8 pages.
  • Show author(s) 2016. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease . New England Journal of Medicine. 1242-1252.
  • Show author(s) 2016. Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. European Journal of Clinical Nutrition. 517-522.
  • Show author(s) 2016. Coronary angiography and myocardial revascularization following the first acute myocardial infarction in Norway during 2001-2009: Analyzing time trends and educational inequalities using data from the CVDNOR project. International Journal of Cardiology. 122-128.
  • Show author(s) 2016. Circulating folate and vitamin B12 and risk of prostate cancer: a collaborative analysis of individual participant data from six cohorts including 6875 cases and 8104 controls. European Urology. 941-951.
  • Show author(s) 2016. B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 495-501.
  • Show author(s) 2016. Association between weight change and mortality in community living older people followed for up to 14 years. The Hordaland Health Study (HUSK). The Journal of Nutrition, Health & Aging. 909-917.
  • Show author(s) 2016. Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris. PLOS ONE.
  • Show author(s) 2015. Novel inflammatory biomarkers in primary hyperparathyroidism. European Journal of Endocrinology (EJE). 9-17.
  • Show author(s) 2015. Markers of vitamin B6 status and metabolism as predictors of incident cancer: The Hordaland Health Study. International Journal of Cancer. 2932-2939.
  • Show author(s) 2015. Kynurenines as predictors of acute coronary events in the Hordaland Health Study. International Journal of Cardiology. 18-24.
  • Show author(s) 2015. Circulating B-vitamins and smoking habits are associated with serum polyunsaturated fatty acids in patients with suspected coronary heart disease: A cross-sectional study. PLOS ONE. 14 pages.
  • Show author(s) 2015. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 455-462.
  • Show author(s) 2015. A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats. Mar. Drugs. Marine Drugs. 5706-5721.
  • Show author(s) 2014. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-gamma-mediated immune activation in the community-based Hordaland health study. British Journal of Nutrition. 1065-1072.
  • Show author(s) 2014. Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a cardiovascular disease in Norway project). American Journal of Cardiology. 1777-1781.
  • Show author(s) 2014. Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Annals of Oncology. 1609-1615.
  • Show author(s) 2014. Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Journal of Bone and Mineral Research. 242-250.
  • Show author(s) 2014. Interferon-γ-induced inflammatory markers and the risk of cancer: The Hordaland Health Study. Cancer. 3370-3377.
  • Show author(s) 2014. Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study. British Journal of Nutrition. 1085-1095.
  • Show author(s) 2014. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • Show author(s) 2014. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • Show author(s) 2014. Favorable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1358-1364.
  • Show author(s) 2014. Educational inequalities in acute myocardial infarction incidence in Norway: A nationwide cohort study. PLOS ONE. 8 pages.
  • Show author(s) 2014. Educational inequalities in 28 day and 1-year mortality after hospitalisation for incident acute myocardial infarction - A nationwide cohort study. International Journal of Cardiology. 874-880.
  • Show author(s) 2013. Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. European Heart Journal. 2689-2696.
  • Show author(s) 2013. Type 2 diabetes genes : present status and data from Norwegian studies. Norsk Epidemiologi. 9-22.
  • Show author(s) 2013. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. American Journal of Clinical Nutrition. 934-940.
  • Show author(s) 2013. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. International Journal of Epidemiology. 201-210.
  • Show author(s) 2013. Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. 297-303.
  • Show author(s) 2013. Plasma stearoyl-CoA desaturase indices: Association with lifestyle, diet and body composition. Obesity. E294-E302.
  • Show author(s) 2013. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. International Journal of Cardiology. 1435-1440.
  • Show author(s) 2013. Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats. PLOS ONE. 9 pages.
  • Show author(s) 2013. Effect of folic acid supplementation on levels of circulating monocyte chemoattractant protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris. PLOS ONE. 11 pages.
  • Show author(s) 2013. Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC Medicine.
  • Show author(s) 2013. Cardiovascular disease and diabetes mellitus in Norway during 1994 -2009: CVDNOR - nationwide research project. Norsk Epidemiologi. 101-107.
  • Show author(s) 2013. Associations between plasma polyunsaturated fatty acids, plasma stearoyl-CoA desaturase indices and body fat. Obesity. E512-E519.
  • Show author(s) 2013. Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patients. PLOS ONE.
  • Show author(s) 2013. An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoE(-/-) mice. PLOS ONE. 14 pages.
  • Show author(s) 2013. A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. British Journal of Nutrition. 648-657.
  • Show author(s) 2013. A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clinical and Experimental Immunology. 121-130.
  • Show author(s) 2012. Relative importance of risk factors for coronary heart disease - The Hordaland Homocysteine Study. Scandinavian Cardiovascular Journal. 316-323.
  • Show author(s) 2012. Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 pages.
  • Show author(s) 2012. Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstetrics and Gynecology. 1243-1250.
  • Show author(s) 2012. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. American Journal of Clinical Nutrition. 1072-1078.
  • Show author(s) 2011. Systemic Markers of Interferon-gamma-Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology. 698-704.
  • Show author(s) 2011. Cobalamin Status Modifies the Effect of Zinc Supplementation on the Incidence of Prolonged Diarrhea in 6-to 30-Month-Old North Indian Children. Journal of Nutrition. 1108-1113.
  • Show author(s) 2011. A proposed method to investigate reliability throughout a questionnaire. BMC Medical Research Methodology. 7 pages.
  • Show author(s) 2010. Serum B vitamin levels and risk of lung cancer. Journal of the American Medical Association (JAMA). 2377-2385.
  • Show author(s) 2010. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a western Norway B vitamin intervention trial (WENBIT) substudy. American Journal of Cardiology. 1577-1584.
  • Show author(s) 2010. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • Show author(s) 2008. Sykehusinnleggelser for hjerte- og karsykdom i Helse Vest i perioden 1992-2001. Tidsskrift for Den norske legeforening. 17-23.
  • Show author(s) 2008. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • Show author(s) 2008. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? American Journal of Clinical Nutrition. 738-746.
  • Show author(s) 2008. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of Nutrition. 914-920.
  • Show author(s) 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • Show author(s) 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12.
  • Show author(s) 2007. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 514-521.
  • Show author(s) 2007. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. American Journal of Clinical Nutrition. 1470-1478.
  • Show author(s) 2006. The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. Journal of Nutrition. 1731-1740.
  • Show author(s) 2006. Relationship between probider-based measures of physical function and self-reported health-realted quality of life in pasients admitted for elective coronary angiafraphy. Heart & Lung. 90-100.
  • Show author(s) 2006. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Show author(s) 2005. Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 277-282.
  • Show author(s) 2004. Changes in lifestyle and plasma total homocysteine. The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 812-819.
  • Show author(s) 2004. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. American Journal of Clinical Nutrition. 641-648.
  • Show author(s) 2004. Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. Blood Pressure Monitoring. 167-172.
  • Show author(s) 2004. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arteriosclerosis, Thrombosis and Vascular Biology. 301-307.
  • Show author(s) 2003. Plasma Vitamin B6 Vitamers before and after Oral Vitamin B6 Treatment: A Randomized Placebo-controlled Study. Clinical Chemistry. 155-161.
  • Show author(s) 2003. Homocysteinstudien i Hordaland. Norsk Epidemiologi. 103-106.
  • Show author(s) 2002. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study. Archives of Internal Medicine. 1374-1381.
  • Show author(s) 2002. Holo-Transcobalamin Is an Early Marker of Changes in Cobalamin Homeostasis. A Randomized Placebo-controlled Study. Clinical Chemistry. 1768-1771.
  • Show author(s) 2001. Plasma total homocysteine is influenced by prandial status in humans: The Hordaland Homocysteine Study. Journal of Nutrition. 1214-1216.
  • Show author(s) 2001. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clinical Chemistry. 1738-1741.
  • Show author(s) 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 130-136.
  • Show author(s) 1999. Apolipoprotein A1 and risk for coronary artery disease. Scandinavian Cardiovascular Journal. 19.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study [see comments]. American Journal of Clinical Nutrition. 263-270.
  • Show author(s) 1998. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 263-270.
  • Show author(s) 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • Show author(s) 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • Show author(s) 1998. Homocystein og koronarsykdom. Lipid-forum. 17-22.
  • Show author(s) 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Show author(s) 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Show author(s) 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Show author(s) 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • Show author(s) 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • Show author(s) 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Show author(s) 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Show author(s) 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Show author(s) 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • Show author(s) 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • Show author(s) 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Show author(s) 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Show author(s) 1996. Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (@z _mmol/liter). The Hordaland Homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Show author(s) 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. Journal of the American Medical Association (JAMA). 1526-1533.
  • Show author(s) 1995. Kolesterolbestemmelse ved sesjon. En måte å identifisere personer med høy risiko for å utvikle hjerte- og karsykdom. Tidsskrift for Den norske legeforening. 3249-3253.
Academic lecture
  • Show author(s) 2020. Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation.
  • Show author(s) 2018. Using metabolic profiling to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study.
  • Show author(s) 2017. Association between dietary fat intake and coronary heart disease in middle-age adults. The Hordaland Health Study (HUSK) .
  • Show author(s) 2015. Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • Show author(s) 2014. VITAMIN D STATUS AND MORTALITY IN PATIENTS WITH STABLE ANGINA.
  • Show author(s) 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
  • Show author(s) 2010. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • Show author(s) 2007. WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • Show author(s) 2007. WENBIT - Western Norway B-vitamin intervention trial.
  • Show author(s) 2007. Total homocysteine, systemic markers of inflammation and long-term mortality in patients with stable angina.
  • Show author(s) 2007. Components of the metabolic syndrome and other cardiovascular risk factors as predictors of plasma choline and betaine.
  • Show author(s) 2007. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in patients with stable angina.
  • Show author(s) 2002. Total homocysteine levels predicts major coronary events and mortaliy in simvastatin treated patients of 4S.
  • Show author(s) 2001. Total homocysteine predicts mortality and major coronary events also in simvastatin treated patients of 4S.
  • Show author(s) 2001. Total homocysteine predicts major coronary events and mortality in simvastatin treated patients of 4S.
  • Show author(s) 2001. Total Homocysteine Levels Predicts Major Coronary Events and Mortality in Simvastatin Treated Patients of 4S.
  • Show author(s) 2001. Homocysteine predicts mortality and coronary events in 4S patients.
  • Show author(s) 1999. Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism.
  • Show author(s) 1999. Apolipoprotein A1 and risk for coronary artery disease.
  • Show author(s) 1998. Plasma total homocysteine: a risk factor for mortality in aortic stenosis patients.
  • Show author(s) 1997. Total mortality and serum uric acid in patients with confirmed coronary artery disease.
  • Show author(s) 1997. Plasma homocysteine predicts mortality in coronary artery diseased patients.
  • Show author(s) 1997. Plasma homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. [Poster].
  • Show author(s) 1995. Plasma homocysteine and relation to coffee and tea comsimption.
  • Show author(s) 1995. Plasma homocystein og forbruk av kaffe og te.
Abstract
  • Show author(s) 2015. A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
  • Show author(s) 2013. DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 241-241.
  • Show author(s) 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
  • Show author(s) 2012. Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • Show author(s) 2012. INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
  • Show author(s) 2009. Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • Show author(s) 2009. Detection of non-viable myocardium by 3T MRI in patients without obstructive coronary artery disease. Cardiology. 88-89.
  • Show author(s) 2009. Delayed contrast-enhancement and left ventricular remodelling demonstrated at high-field 3T MRI of patients with suspected coronary artery disease. Cardiology. 82-83.
  • Show author(s) 2008. The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease. Circulation. E345-E346.
  • Show author(s) 2008. The effect of homocysteine-lowering B-vitamin intervention on angiographic coronary artery disease may be adverse - A WENBIT sub-study. Circulation. E334-E334.
  • Show author(s) 2008. Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy. Circulation. E487-E487.
  • Show author(s) 2008. Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study. Circulation. E472-E473.
  • Show author(s) 2008. Homocysteine and markers of immune activation as predictors of mortality in stable angina patients. Circulation. E351-E351.
  • Show author(s) 2008. B6 vitamers and long term mortality in patients with stable angina. Circulation. E347-E347.
  • Show author(s) 2008. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in both men and women with stable angina. Circulation. E342-E342.
  • Show author(s) 2007. Predictors of plasma choline and betaine: The Hordaland Homocysteine Study. Clinical Chemistry and Laboratory Medicine. A18-A19.
  • Show author(s) 2005. The Effect of Homocysteine Lowering Therapy on Inflammatory Markers Neopterin and CRP in Patients with Stable Coronary Artery Disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). Haematalogica Reports. 66-66.
  • Show author(s) 2005. Effect of homocysteine lowering therapy on coronary endothelial function in patients with stable coronary artery disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). European Heart Journal. 477-477.
  • Show author(s) 2005. Effect of Homocysteine Lowering Therapy on Coronary Endothelial Function in Patients with Stable Coronary Artery Disease. Haematalogica Reports. 10-10.
Academic literature review
  • Show author(s) 2015. The chromosome 9p21 CVD- and T2D-associated regions in a Norwegian population (the HUNT2 survey). International Journal of Endocrinology. 9 pages.
  • Show author(s) 2012. The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice. 15 pages.
  • Show author(s) 2010. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals. Archives of Internal Medicine. 1622-1631.
  • Show author(s) 2010. Circulating folate, vitamin B-12, homocysteine, vitamin B-12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiology, Biomarkers and Prevention. 1632-1642.

More information in national current research information system (CRIStin)

Research groups